Targeting T-cell mediated inflammation improves cardiac dysfunction and metabolic remodelling in type 2 diabetes. (31st December 2022) - Anderson, Stephanie; Barnes, Michael; Karlstaedt, Anja; Albee, Lauren; Shattock, Michael; O'Riordan, Caroline; Henson, Sian; Cvetko, Filip; Prag, Hiran; Lewis, Andrew; Murphy, Michael; Smith, Dave; et al.